Constitutional Telomerase Mutations Are Genetic Risk Factors for Cirrhosis
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
19/10/2012
19/10/2012
2011
|
Resumo |
Some patients with liver disease progress to cirrhosis, but the risk factors for cirrhosis development are unknown. Dyskeratosis congenita, an inherited bone marrow failure syndrome associated with mucocutaneous anomalies, pulmonary fibrosis, and cirrhosis, is caused by germline mutations of genes in the telomerase complex. We examined whether telomerase mutations also occurred in sporadic cirrhosis. In all, 134 patients with cirrhosis of common etiologies treated at the Liver Research Institute, University of Arizona, between May 2008 and July 2009, and 528 healthy subjects were screened for variation in the TERT and TERC genes by direct sequencing; an additional 1,472 controls were examined for the most common genetic variation observed in patients. Telomere length of leukocytes was measured by quantitative polymerase chain reaction. Functional effects of genetic changes were assessed by transfection of mutation-containing vectors into telomerase-deficient cell lines, and telomerase activity was measured in cell lysates. Nine of the 134 patients with cirrhosis (7%) carried a missense variant in TERT, resulting in a cumulative carrier frequency significantly higher than in controls (P = 0.0009). One patient was homozygous and eight were heterozygous. The allele frequency for the most common missense TERT variant was significantly higher in patients with cirrhosis (2.6%) than in 2,000 controls (0.7%; P = 0.0011). One additional patient carried a TERC mutation. The mean telomere length of leukocytes in patients with cirrhosis, including six mutant cases, was shorter than in age-matched controls (P = 0.0004). Conclusion: Most TERT gene variants reduced telomerase enzymatic activity in vitro. Loss-of-function telomerase gene variants associated with short telomeres are risk factors for sporadic cirrhosis. (HEPATOLOGY 2011;53:1600-1607) National Institutes of Health (NIH) Pfizer |
Identificador |
HEPATOLOGY, v.53, n.5, p.1600-1607, 2011 0270-9139 http://producao.usp.br/handle/BDPI/24050 10.1002/hep.24173 |
Idioma(s) |
eng |
Publicador |
WILEY-BLACKWELL |
Relação |
Hepatology |
Direitos |
closedAccess Copyright WILEY-BLACKWELL |
Palavras-Chave | #CHRONIC HEPATITIS-C #IDIOPATHIC PULMONARY-FIBROSIS #GENOME-WIDE ASSOCIATION #BONE-MARROW FAILURE #DYSKERATOSIS-CONGENITA #APLASTIC-ANEMIA #LIVER FIBROSIS #REVERSE-TRANSCRIPTASE #SUSCEPTIBILITY LOCI #DISEASE #Gastroenterology & Hepatology |
Tipo |
article original article publishedVersion |